Skip Navigation

Cardiovascular Research 2001 51(2):294-303; doi:10.1016/S0008-6363(01)00303-0
© 2001 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Eaton, P.
Right arrow Articles by Shattock, M. J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Eaton, P.
Right arrow Articles by Shattock, M. J
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2000, European Society of Cardiology

Lipid hydroperoxide modification of proteins during myocardial ischaemia

Philip Eaton*, David J Hearse and Michael J Shattock

Cardiovascular Research, The Centre for Cardiovascular Biology and Medicine, King's College London, The Rayne Institute, St. Thomas' Hospital, London, SE1 7EH, UK

* Corresponding author. Tel.: +44-171-928-9292 (ext. 2749); fax: +44-171-922-8139 philip.eaton{at}kcl.ac.uk

Objective: Lipid hydroperoxides (LOOH) are lipid peroxidation products formed during oxidative stress. A component of their cytotoxicity is mediated by the direct modification of proteins. Objectives: (i) To assess whether ischaemia and reperfusion in the isolated rat heart generates LOOH–protein (ii) to characterise the extent, time-course and subcellular localization of any protein adducts formed. Methods: Using a well-characterised antibody which binds to LOOH-modified proteins and densitometry of Western blots, we quantified the amounts of LOOH–protein in control aerobically perfused rat hearts and those subjected to ischaemia with and without reperfusion. Results: Hearts (n=3/4 group), analysed after various periods (0, 5, 10, 20 and 30 min) of zero-flow global ischaemia, exhibited a time-dependent increase in the LOOH-mediated modification of a number of proteins. In hearts subjected to 30 min of ischaemia and then reperfused for various times (0, 5, 10, 20, 30 or 60 min) no changes in LOOH–protein content achieved during the proceeding ischaemic episode were detected. Reperfusion after short periods of ischaemia (5 or 10 min) also did not result in reperfusion-induced LOOH–protein formation. Administration of mercaptopropionylglycine (1 mM) to hearts for 5 min before the onset of 30 min ischaemia efficiently attenuated the formation of LOOH–protein, maintaining the modified proteins at control levels. These Western immunoblot results were confirmed by additional in situ immunofluorescent studies which showed marked LOOH–protein immunostaining in ischaemic tissue around the sarcolemmal membrane. Conclusions: We conclude that the modification of proteins (particularly those associated with sarcolemmal membranes) by LOOH during ischaemia may contribute to the pathophysiology of ischaemic injury. In addition, these modifications may be initiators of oxidant-induced signal transduction pathways. These findings are consistent with an oxidant stress occurring during ischaemia which is not exacerbated or reduced during the first 60 min of reperfusion.

KEYWORDS LOOH, lipid hydroperoxide; HNE, hydroxynonenal; MPG, mercaptopropionylglycine


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
G. R. Lee, D. Bell, E. J. Kelso, C. C. H. Argent, and B. J. McDermott
Evidence for altered ETB receptor characteristics during development and progression of ventricular cardiomyocyte hypertrophy
Am J Physiol Heart Circ Physiol, July 1, 2004; 287(1): H425 - H432.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Canton, I. Neverova, R. Menabo, J. Van Eyk, and F. Di Lisa
Evidence of myofibrillar protein oxidation induced by postischemic reperfusion in isolated rat hearts
Am J Physiol Heart Circ Physiol, March 1, 2004; 286(3): H870 - H877.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Coll. Nutr.Home page
S. J. Padayatty, A. Katz, Y. Wang, P. Eck, O. Kwon, J.-H. Lee, S. Chen, C. Corpe, A. Dutta, S. K Dutta, et al.
Vitamin C as an Antioxidant: Evaluation of Its Role in Disease Prevention
J. Am. Coll. Nutr., February 1, 2003; 22(1): 18 - 35.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. Skyschally, R. Schulz, P. Gres, H.-G. Korth, and G. Heusch
Attenuation of ischemic preconditioning in pigs by scavenging of free oxyradicals with ascorbic acid
Am J Physiol Heart Circ Physiol, February 1, 2003; 284(2): H698 - H703.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.